|1.||Bloom, Stephen R: 13 articles (11/2015 - 12/2002)|
|2.||Ghatei, Mohammad A: 6 articles (07/2010 - 12/2002)|
|3.||Flatt, Peter R: 5 articles (11/2015 - 12/2010)|
|4.||Wynne, Katie: 5 articles (10/2010 - 08/2005)|
|5.||Pocai, Alessandro: 4 articles (06/2014 - 10/2009)|
|6.||Field, Benjamin C T: 4 articles (08/2010 - 01/2008)|
|7.||Patterson, Michael: 4 articles (07/2010 - 10/2003)|
|8.||Irwin, Nigel: 3 articles (11/2015 - 12/2013)|
|9.||Gault, Victor A: 3 articles (11/2014 - 12/2010)|
|10.||Marsh, Donald J: 3 articles (08/2012 - 10/2009)|
11/01/2015 - "Oxyntomodulin analogues offer a novel treatment for obesity. "
08/01/2012 - "Nonclinical studies on two potential treatments for obesity, oxyntomodulin and PYY 3-36, are also presented to illustrate the relationship between exposure and effect as functions of route of administration."
03/01/2015 - "Oxyntomodulin (OXM1-37) is an anorectic gut-secreting peptide with a promise to treat obesity, but its needle-free delivery has yet to be successful. "
11/15/2014 - "Oxyntomodulin (Oxm) possesses beneficial biological actions for the potential treatment of obesity-diabetes. "
10/01/2010 - "This review discusses the role of oxyntomodulin in the physiological control of appetite, and presents the currently available evidence suggesting its potential as an obesity treatment."
|2.||Body Weight (Weight, Body)
12/01/2010 - "To determine the efficacy of a long-acting oxyntomodulin (OXM) analogue, OXM6421, in inhibiting food intake and decreasing body weight in lean and diet-induced obese (DIO) rodents. "
03/01/2015 - "Pulmonary delivery of anorectic oxyntomodulin in rats: food intake suppression, reduced body weight gain and pharmacokinetics."
12/01/2010 - "Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents."
09/01/2009 - "[Expression of oxyntomodulin in bifidobacteria and effect of oxyntomodulin-transformed bifidobacteria on the body weight of obese mice]."
04/01/2009 - "Oxyntomodulin (Oxm) is an intestinal peptide that inhibits food intake and body weight in rodents and humans. "
|3.||Weight Loss (Weight Reduction)
10/01/2010 - "The administration of oxyntomodulin to animals and humans causes weight loss by reducing food intake in combination with increasing energy expenditure. "
01/01/2006 - "When given preprandially by subcutaneous injection three times daily, oxyntomodulin resulted in a reduction in food intake and mean weight loss of 2.8kg over 4 weeks. "
02/01/2011 - "Peripherally, dual blockade of cannabinoid and NPY pathways has synergistic effects on weight loss, as does combined administration of PYY3-36 and oxyntomodulin in reducing food intake, perhaps due to the recently discovered role of PYY in mediating intestinal Gpr119 activity and controlling glucose tolerance. "
11/01/2006 - "The weight loss that has been observed in animal models after repeated administration of oxyntomodulin and PYY has led to interest in developing these peptides as antiobesity therapies in humans. "
08/01/2005 - "Oxyntomodulin treatment resulted in weight loss and a change in the levels of adipose hormones consistent with a loss of adipose tissue. "
12/01/2006 - "Oxyntomodulin increases energy expenditure in addition to decreasing energy intake in overweight and obese humans: a randomised controlled trial."
07/01/2010 - "The anorectic effects of PYY(3-36) and oxyntomodulin can be additive in overweight and obese humans. "
07/01/2010 - "PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans."
12/01/2006 - "To determine whether oxyntomodulin alters energy expenditure, in addition to reducing energy intake, in 'free-living' overweight and obese volunteers. "
11/01/2006 - "Indeed, preliminary studies have found that oxyntomodulin or PYY administration reduces food intake and body weight effectively in overweight human volunteers. "
|5.||Pancreatic Polypeptide (Pancreatic Polypeptide (PP))
|6.||Islet Amyloid Polypeptide
|7.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|10.||Glucagon-Like Peptide 1 (GLP 1)